TREATMENT OF SEVERE PNEUMONIA BY ADMINISTRATION OF TISSUE FACTOR PATHWAY INHIBITOR
Application 642/KOLNP/2004 published 2006-04-14, filed 2004-05-17
Methods for prophylactically or therapeutically treating severe pneumonia involve administration of tissue factor pathway inhibitor (TFPI) or a TFPI analog to patients suffering from or at risk of developing this condition. The methods involve the use of continuous intravenous infusion of TFPI or a TFPI analog, preferably at low doses to avoid adverse side effects. (FIG. - nil)
Applicant
CHIRON CORPORATION
4560 HIORTON STREET, EMERVILLE CA 94608-291 USA
Inventor
CREASEY ABLA A
International Info
Classification: A61K
Publication Number: WO 03/032904 A2
Application Date: 2002-10-15
Priority Information
60/328,806 US 1920-10-15